| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Edgewise Therapeutics, Inc. (EWTX) have been net sellers, shedding 43,429 shares worth roughly $1.9M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 52.5K | $1.98M | - | |
| Other | 31.8K | $1.20M | - | |
| Other | 31.5K | $1.19M | - | |
| Dir | 25.1K | $947.3K | - | |
| Dir | 19.8K | $746.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | R Michael Carruthers46 | Chief Financial Officer | Sale+OE | 125,092 | $28.57 | $3,573,979.93 | -94.8% | +8.9% | -49.6% | |
| May 2, 2024 | Kevin Koch51 | President and CEO | Sale+OE | 3,152 | $18.91 | $59,604.32 | -17.9% | -11.7% | -12.3% | |
| May 2, 2024 | Joanne M. Donovan49 | CMO | Sale+OE | 3,682 | $18.91 | $69,626.62 | -15.6% | -11.7% | -12.3% | |
| May 2, 2024 | Alan J Russell74 | Chief Scientific Officer | Sale+OE | 1,576 | $18.91 | $29,802.16 | -17.9% | -11.7% | -12.3% | |
| May 2, 2024 | Behrad Derakhshan50 | Chief Business Officer | Sale+OE | 1,718 | $18.91 | $32,487.38 | -11.3% | -11.7% | -12.3% | |
| May 2, 2024 | R Michael Carruthers46 | Chief Financial Officer | Sale+OE | 2,157 | $18.91 | $40,788.87 | -5.8% | -11.7% | -12.3% | |
| May 2, 2024 | John R Moore | General Counsel | Sale+OE | 1,956 | $18.91 | $36,987.96 | -37.6% | -11.7% | -12.3% | |
| Feb 9, 2024 | John R Moore | General Counsel | Sale+OE10b5-1 | 29,835 | $20.00 | $596,805.46 | - | +2.7% | +35.4% | |
| Feb 9, 2024 | Behrad Derakhshan50 | Chief Business Officer | Sale+OE10b5-1 | 10,000 | $20.03 | $200,258.04 | -58.8% | +2.7% | +35.4% | |
| Jan 23, 2024 | R Michael Carruthers46 | Chief Financial Officer | Sale+OE10b5-1 | 90,000 | $15.78 | $1,419,759.00 | -75.6% | -2.5% | +75.5% |